Latest Headlines

Latest Headlines

CSL nets closeout letter after FDA violations

After more than two years of manufacturing problems, CSL Biotherapies cleaned up its act, receiving a closeout letter from the FDA.

J&J's boost in Doxil supply benefits study of Endocyte/Merck drug

Johnson & Johnson has come through with more of its cancer drug Doxil to fill orders from biotechs that need the drug for their clinical trials, after months of rationing the drug because of a key supplier's manufacturing problems.

Dendreon to slash 600 more jobs as Provenge sales lag

It's another round of cutbacks for Dendreon. As sales of its prostate cancer treatment Provenge continue to lag, the Seattle-based company says it will cut 600 jobs and shutter a New Jersey manufacturing plant. That's 41% of its current 1,475-employee workforce.

Dendreon shares plunge as new CEO brings out the ax (again)

As sales of Provenge continued to disappoint in the first half of the year, Dendreon's new CEO opted to trigger another big restructuring at the Seattle-based biotech, with plans to cut 600 jobs and shutter one of its three manufacturing sites in an effort to slash his way to profitability.

FDA wags finger at Sanofi for no-nos at vaccine plants

The FDA admonished Sanofi Pasteur on more than two dozen counts for "objectionable" conditions in two plants in Canada and France, according to a warning letter dated July 12 and made public July 24.

Novartis leans on emerging markets, new meds to offset Diovan drop

Novartis is gaining in emerging markets. It's also seeing growth in newly launched products, including a few potential blockbusters. Both very good things--and sorely needed to offset a manufacturing shutdown and eroding sales of its top-selling drug.

Sanofi mulls up to 2,000 job cuts in France, unions say

Sanofi is gearing up for thousands of job cuts in its home country.

Budget chainsaw may miss Sanofi manufacturing

Sanofi's ($SNY) manufacturing operations in France may be spared cuts as the company makes further reductions in operations. A spokesman confirmed to Reuters that the company is looking at reductions there, but said manufacturing operations would not be included.

India accelerates push for modern medical device regs

As medical device companies increasingly turn to India for business, manufacturing and R&D, the country's Health Ministry is trying to advance a bill that would modernize the country's regulations for the industry.

Roche Diagnostics commits $300M to Indianapolis expansion

Roche Diagnostics will pour $300 million over the next decade into its Indianapolis headquarters. The end goal here is to beef up its operations there and add 100 new jobs in the process, the Indianapolis Star reports.
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • next ›
  • last »